ICRA Limited · Mankind Pharma Limited: Ratings reaffirmed for existing instruments and assigned for commercial paper programmeICRA Limited · PDF preserved by IndiaTicker
Archived PDF Company dossier
Mankind Pharma
NSE:MANKIND · ISIN INE634S01028
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Mankind Pharma
Ratings & risks
Credit signals
Agency evidenceRating-action history
CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF ICRA Limited · Mankind Pharma Limited: Ratings reaffirmedICRA Limited · PDF preserved by IndiaTicker
Archived PDF ICRA Limited · Mankind Pharma Limited: Rating withdrawn for Rs. 1,500 crore commercial paper programme; ratings outstanding for bank loan facilities and non-convertible debenture programmeICRA Limited · PDF preserved by IndiaTicker
Archived PDF ICRA Limited · Mankind Pharma Limited: Rating withdrawn for Rs. 3,500 crore commercial paper programme; ratings outstanding for bank loan facilities, non-convertible debenture programme and Rs. 1,500 crore commercial paper programmeICRA Limited · PDF preserved by IndiaTicker
Archived PDF CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF ICRA Limited · Mankind Pharma Limited: Long-term rating reaffirmed; short-term rating reaffirmed/ assignedICRA Limited · discovered
Agency source ICRA Limited · Mankind Pharma Limited: Ratings reaffirmed for existing non-convertible debentures; ratings assigned for bank loans, commercial papers and non-convertible debenturesICRA Limited · discovered
Agency source ICRA Limited · Mankind Pharma Limited - Update on Material EventICRA Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source ICRA Limited · Mankind Pharma Limited: Rating assignedICRA Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source Risk research framework
Analyst reviewQuestions to test against evidence
Operating deterioration
HighTrack sector-specific operating metrics and reconcile them across reporting periods.
Funding and liquidity
HighReview debt maturity, repricing, liquidity and rating commentary where relevant.
Execution versus guidance
MediumCompare management statements with subsequent reported delivery.
Governance and key-person change
MediumConnect management transitions, related parties and auditor observations.